Cell Analysis Industry on Track to Reach $33.9 Billion by 2028
The global cell analysis market , valued at $20.2 billion in 2023, is set to reach $33.9 billion by 2028, with a CAGR of 10.9%. This growth is largely due to the increasing use of cell-based assays and strong research funding. The new research study analyzes industry trends, pricing, patents, and stakeholder behavior, illustrating how cell-based assays offer a more efficient alternative to traditional toxicity assessments in drug development. Download PDF Brochure Cell Analysis Market Dynamics DRIVER: Growing number of drug discovery activities Adoption of cell-based screening assays has increased in he drug discovery activities to understand associated complexities. Additionally, advances in cell biology, bioinformatics, molecular biology, genomics, and proteomics have generated large volumes of data, owing to which the use of cell-based assays in the drug development process has gained importance. Similarly, the Human Genome Project has generated a number of targets on which drug scr...